Could a brain cancer drug target tumor activity? early trial launches
Disease control
Recruiting now
This early-phase trial tests the drug troriluzole in 27 adults with recurrent IDH wild-type glioblastoma, an aggressive brain cancer. Participants take the drug before surgery, and researchers measure brain activity and glutamate levels in the removed tumor tissue. The goal is to…
Early phase 1 • Sponsor: Ugonma Chukwueke • Aim: Disease control
Last updated Jun 26, 2026 16:51 UTC